Nottingham, U.K., Jun. 14, 2018 — Quotient Sciences (“Quotient”), the drug development services organization, is delighted to be selected as the winner of the Outstanding Achievement award at last night’s Medilink East Midlands Business Awards. The Awards, which are held as part of the region’s premier life science event, Innovation Day, recognize organizations in the sector who, in the past year, have excelled in their individual categories.The Outstanding Achievement award recognizes organizations which have celebrated momentous success or development. Quotient has experienced continued growth and global expansion following a series of acquisitions in 2017 and now employs over 700 employees across six operating sites within the U.K. and U.S. Quotient is focused on delivering an innovative portfolio of services, including a unique Translational Pharmaceutics® platform that is proven to shorten drug development timelines, reduce costs and accelerate the delivery of new medicines to patients.
Mark Egerton, CEO Quotient Sciences said “We are delighted to have won the Outstanding Achievement award. It is great recognition for all the hard work of the last few years’ and the continuous dedication of our staff. Thanks to an incredible team, we have repeatedly demonstrated that Translational Pharmaceutics® can deliver significant time and cost savings for our customers, helping them to increase their overall R&D productivity”
Quotient will go on to be shortlisted for a Medilink UK Healthcare Business Award, with the chance to be crowned national winners in 2019.
View this press release here